Haiyan Xu

1.8k citations
105 papers · 1.3k indexed · h-index 21

Haiyan Xu

95 papers receiving 1.3k citations

Peers

Haiyan Xu
Comparison fields: 5 of 124
  • Pharmacology 113
  • Cancer Research 182
  • Complementary and alternative medicine 66
  • Cardiology and Cardiovascular Medicine 177
  • Molecular Biology 531
Replace Tingting Guo with:
Tingting Guo China
Dawei Wang China
Yanjun Zheng China
Umashanker Navik India
Srinivas Gopala India
Yoosik Yoon South Korea
Katarzyna Wójcik‐Pszczoła Poland
Dong Kwon Yang South Korea
Pengli Zhu China
Haiyan Xu relative to Tingting Guo China Tingting Guo's profile →
Citations per field
00.5×3.7×
Tingting Guo · 1×
Citations per year

Countries citing papers authored by Haiyan Xu

Since Specialization
Citations

This map shows the geographic impact of Haiyan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyan Xu more than expected).

Fields of papers citing papers by Haiyan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiyan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyan Xu. The network helps show where Haiyan Xu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Haiyan Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Haiyan Xu Line = papers co-authored together Haiyan Xu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20255
3 20250
4 20252
5 20250
6 20246
7 20241
8 202423
9 202312
10 20232
11 20237
12 20231
13 20212
14 201916
15 20198
16 201725
17 20171
18 201628
19 20158
20
[Expression of serum FSTL-1 in bone metastasis of prostate cancer and its clinical implication].
20143

About Haiyan Xu

Haiyan Xu is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Complementary and alternative medicine, having authored 105 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (7 papers), Cardiovascular Function and Risk Factors (6 papers), Cancer-related molecular mechanisms research (6 papers), Pharmacogenetics and Drug Metabolism (5 papers), RNA modifications and cancer (5 papers), Salmonella and Campylobacter epidemiology (4 papers), Cardiac pacing and defibrillation studies (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Pharmacology (113 citations), Cancer Research (182 citations) and Complementary and alternative medicine (66 citations). Haiyan Xu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yuanyuan Zhang, Rui Yang, Linhui Gu, Yi Jin, Jianguo Feng, Dafang Zhong, Stephen W.J. Wang, Kaustubh H. Kulkarni, Rashim Singh and Ming Hu. Their work appears in journals such as Frontiers in Public Health, Journal of Agricultural and Food Chemistry, International Journal of Cardiology, Journal of Ethnopharmacology and Gene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026